Search results

  1. Do the direct anterior, direct superior and supercapsular percutaneously assisted (SuperPATH) approaches to hip replacement improve patient-recorded outcome measures and reduce length of hospital stays, revision rates, neurological complications and surgical site infections compared with the posterior and anterolateral approaches?

    Recommendation ID NG157/11 Question Do the direct anterior, direct superior and supercapsular percutaneously assisted (SuperPATH) approaches

  2. Evidence on the safety and efficacy of artificial iris implant insertion for acquired aniridia is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.  Find out  what special arrangements mean on the NICE website .

    Recommendation ID IPG674 Question Evidence on the safety and efficacy of artificial iris implant insertion for acquired aniridia is limited

  3. Hepatitis B (chronic)

    Everything NICE has said on diagnosing and managing chronic hepatitis B in children, young people and adults in an interactive flowchart

  4. Further research is recommended to assess the effect of test-guided preventive care (see section 5.1) on clinical outcomes (such as length of stay in hospital, mortality and need for renal replacement therapy and progression to chronic kidney disease). Research should be done in children, young people and adults, but specific considerations may be needed for children and young people when care differs from that for an adult population. Studies should investigate the effects of both positive and negative test results on clinical decisions and subsequent care.

    Recommendation ID DG39/2 Question Further research is recommended to assess the effect of test-guided preventive care (see section 5.1)

  5. Companies should specify patient populations in the NHS who could benefit from test-guided preventive care for acute kidney injury. Further research is then recommended in these populations to assess the clinical effectiveness of defined care bundles designed to prevent or reduce the effect of acute kidney injury in the NHS. Research should be done in children, young people and adults, but specific considerations may be needed for children and young people when care differs from that for an adult population (see  section 4.11 ).

    Recommendation ID DG39/1 Question Companies should specify patient populations in the NHS who could benefit from test-guided preventive

  6. Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.  Find out  what only in research means on the NICE website .

    Recommendation ID IPG676 Question Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises

  7. Motor neurone disease

    Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart

  8. Eye conditions

    Everything NICE has said on eye conditions in an interactive flowchart

  9. Chronic heart failure

    Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

  10. Myeloma

    Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart

  11. Advanced breast cancer

    Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart

  12. Constipation

    Everything NICE has said on constipation in an interactive flowchart

  13. Non-alcoholic fatty liver disease

    Everything NICE has said on diagnosing and managing non-alcoholic fatty liver disease and advanced liver fibrosis in an interactive flowchart

  14. Renal and ureteric stones (QS195)

    This quality standard covers assessing and managing renal and ureteric stones in children, young people and adults. It describes high-quality care in priority areas for improvement.

  15. Cirrhosis

    Everything NICE has said on assessing and managing suspected or confirmed cirrhosis in people over 16 in an interactive flowchart

  16. Child abuse and neglect

    Everything NICE has said on child abuse and neglect in an interactive flowchart

  17. Autism spectrum disorder

    Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

  18. Neonatal jaundice

    Everything NICE has said on diagnosing and treating jaundice in newborn babies under 28 days in an interactive flowchart

  19. Specialist neonatal respiratory care for babies born preterm (QS193)

    This quality standard covers neonatal respiratory support in hospital for babies born preterm (before 37 weeks of pregnancy). It describes high-quality care in priority areas for improvement.

  20. Pancreatitis

    Everything NICE has said on pancreatitis in an interactive flowchart

  21. Organ donation for transplantation

    Everything NICE has said on improving donor identification and consent rates for deceased organ donation for transplantation in an interactive flowchart

  22. Neonatal parenteral nutrition

    Everything NICE has said on parenteral nutrition (intravenous feeding) for newborn babies in an interactive flowchart.

  23. Neurological conditions

    Everything NICE has said on neurological conditions in an interactive flowchart

  24. Cardiovascular disease prevention

    Everything NICE has said on cardiovascular risk assessment and modifying blood lipids for preventing cardiovascular disease in adults

  25. Patient group directions

    Everything NICE has said on systems and processes to develop, authorise, use, and update patient group directions in an interactive flowchart

  26. Liver conditions

    Everything NICE has said on liver conditions in an interactive flowchart

  27. Liver cancers

    Everything NICE has said on liver and bile duct cancers in an interactive flowchart

  28. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  29. Sepsis (QS161)

    This quality standard covers the recognition, diagnosis and early management of sepsis for all populations. It describes high-quality care in priority areas for improvement.

  30. Local formulary development

    Everything NICE has said on systems and processes for developing and updating local formularies in an interactive flowchart

  31. Attention deficit hyperactivity disorder

    Everything NICE has said on diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults in an interactive flowchart

  32. Sepsis

    Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart

  33. Domestic violence and abuse

    Everything NICE has said on identifying, preventing and reducing domestic violence and abuse in an interactive flowchart

  34. Acutely ill patients in hospital

    Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart